baber/WOPTO huggingface dataset:
Patent MX-2020011054-A (MX)
Title: Method for machining at least one electrical enclosure.
Inventor: BOEHME SIEGFRIED
IPC: H02B3/00
Filed: 2019-03-22
Abstract: The invention relates to a method for machining at least one electrical enclosure, having the steps of: - providing at least one electrical enclosure which consists of multiple parts and has at least one removably assembled component; - disassembling and removing the removably assembled component from the electrical enclosure; - machining the disassembled and removed component and providing the machined component for reassembling on the corresponding electrical enclosure; and - reattaching the machined component provided for reassembly to the corresponding electrical enclosure. The invention is characterized in that the at least one electrical enclosure has an individual machine-readable electrical enclosure marker, and the at least one removably assembled component has an individual machine-readable component marker, said markers being assigned to each other. The step of reattaching the component to the electrical enclosure includes the process of machine-reading the machine-readable marker and the process of joining the component and the electrical enclosure which have markers that are assigned to each other.
Patent MX-2020011336-A (MX)
Title: One pot synthesis of 4-(1,2-dihydro-2-oxobenzo[d]imidazol-3-yl)bu tanoic acid, a key intermediate of zilpaterol.
Inventor: RAVI KUMAR KANNASANI
IPC: C07C271/22
Filed: 2019-03-04
Abstract: The present invention relates to one pot process for the preparation of 4-(1,2-dihydro-2-oxobenzo[d]imidazol-3-yl)butanoic acid of Formula- I, which is a key intermediate and its use in the preparation of Zilpaterol, which comprises condensation of methyl-4-chloro butyrate with 1-(prop-1-en-2-yl)-1H-benzo[d]imidazol-2(3H)-one in presence of a base and suitable solvent to give corresponding ester derivative, further hydrolyzation and acidification in presence of inorganic solvent to obtain Formula- I.
Patent MX-2020011877-A (MX)
Title: Codon-optimised cry1da nucleic.
Inventor: PORTILHO CARNEIRO NEWTON
IPC: C12N5/14
Filed: 2019-04-30
Abstract: The invention relates to novel cry1Da nucleic acid molecules which are codon-optimised on the basis of a gene sequence isolated from the Bacillus thuringiensis bacterium. These molecules are used to produce nucleic acid constructs, vectors and host cells, allowing the production of transgenic plants, such as corn, which are resistant to invertebrate pests, such as insects of the order Lepidoptera, particularly Spodoptera frugiperda (Noctuidae, Lepidoptera) and Diatrea saccharalis (Crambidae, Lepidoptera). The invention also relates to plant cells and transgenic plants comprising the molecules or the constructs according to the invention. Particularly, transgenic plants according to the present invention can control caterpillars of the above-mentioned species which have become resistant to the plants containing the gene <i>cry1F</i>. The invention further relates to a method for transforming a cell, to a method for controlling invertebrate pests of crop plants, and to the uses of the molecules or nucleic acid constructs for producing transgenic plants and for controlling invertebrate pests.
Patent MX-2021001754-A (MX)
Title: Novel sulfonamideurea compounds.
Inventor: MILLER DAVID
IPC: C07D471/08
Filed: 2019-08-12
Abstract: The present invention relates to compounds of formula (I): wherein Q is selected from O or S; R<sup>1</sup> and R<sup>3</sup> are each independently hydrogen or an optionally substituted hydrocarbyl group, or R<sup>1</sup> and R<sup>3</sup> together with the nitrogen atom to which they are attached may form a 3- to 12-membered optionally substituted cyclic group; and R<sup>2</sup> is a cyclic group substituted at the oposition, wherein R<sup>2</sup> may optionally be further substituted. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP3.
Patent MX-2021002335-A (MX)
Title: Method and device for measuring a flow velocity of a gas stream.
Inventor: CONRADS HANS- GEORG
IPC: G01F1/704
Filed: 2019-09-24
Abstract: The invention relates to a method for measuring a flow velocity (v) of a gas stream (14), comprising the steps of: (a) time-resolved measuring of an IR radiation parameter (E) of IR radiation of the gas stream (14) to a first measurement point (P1) outside the gas stream (14), such that a first IR radiation parameter curve (E<sub>g1,1</sub>(t)) is obtained, (b) time-resolved measuring of an IR radiation parameter (E) at a second measurement point (P2) outside the gas stream (14), such that a second IR radiation parameter curve (E<sub>g1,2</sub>(t)) is obtained, (c) calculating a transit time (Ï1) from the first IR radiation parameter curve (E<sub>g1,1</sub>(t)) and the second IR radiation parameter curve (E<sub>g1,2</sub>(t)), in particular by means of cross-correlation, and (d) calculating the flow velocity (vG) from the transit time (Ï1), (e) the IR radiation parameter (E<sub>g1</sub>) being measured photoelectrically at a wavelength (g1) of at least 780 nm and (f) a measurement frequency (f) amounting to at least 1 kilohertz.
Patent MX-2021002672-A (MX)
Title: An improved process for the preparation of recombinant lectin protein.
Inventor: SATHE DHANANJAY
IPC: C07K14/42
Filed: 2019-09-05
Abstract: The present invention relates to the process to prepare recombinant lectin having amino acid sequence of SEQ ID NO:l, wherein the process comprises fed-batch fermentation of a clone in a host cell at specific feeding rate with carbon to Nitrogen ratio of 3:1 to 6:1. The invention also relates to the process of purification of recombinant lectin having amino acid sequence of SEQ ID NO: 1.
Patent MX-2021006243-A (MX)
Title: Synergistic compositions comprising (r)-2-(2-oxopyrrolidin-1-yl)b utanamide and (s)-2-(2-oxopyrrolidin-1-yl)butanamide in a non-racemic ratio.
Inventor: SCHERZ MICHAEL
IPC: A61P25/24
Filed: 2019-12-04
Abstract: The present invention relates to a composition of the enantiomers of 2-(2-oxopyrrolidin-1- yl)butanamide and pharmaceutically acceptable solvates or co-crystals thereof in a certain ratio, a pharmaceutical composition comprising said composition, its use as a medicament and the use of the inventive compositions or pharmaceutical compositions in the treatment and/or prevention of a disease or disorder typically and preferably selected from seizure-related disorders, peripheral sensory neuropathy, preferably peripheral neuropathic pain; seizure; depression; or cognitive impairment.
Patent MX-2021008758-A (MX)
Title: Methods and apparatus to selectively extract constituents from biological samples.
Inventor: SEBBA DAVID S
IPC: G01N1/40
Filed: 2020-01-23
Abstract: Methods and apparatus provide filtration for concentrating analytes, such as bacteria or exosomes, of a biological sample, such as blood or urine. The technology may employ membrane devices that implement one or more tangential flow filtration processes such as in stages. An example membrane device may typically include a membrane having sides and ends. The membrane may selectively permit constituent(s) of the sample to pass through while retaining other constituents at one side. An input chamber of the device may include an inlet near one end and an outlet near the other end, and that may permit a tangential flow of the sample along the first side surface, and a trans-membrane passing of constituent(s). An output chamber of the device may be configured at the second side surface to receive the passing constituents. Such devices may be provided in a kit to facilitate targeting of a desired biological analyte concentration.
Patent MX-2021009401-A (MX)
Title: Adeno-associated virus delivery of cln3 polynucleotide.
Inventor: FOUST KEVIN
IPC: C12N15/86
Filed: 2020-02-04
Abstract: The present disclosure relates to recombinant adeno-associated virus (rAAV) delivery of a ceroid lipofuscinosis neuronal 3 (CLN3) polynucleotide. The disclosure provides rAAV and methods of using the rAAV for CLN3 gene therapy of the neuronal ceroid lipofuscinosis or CLN3 -Batten Disease.
Patent MX-2021009988-A (MX)
Title: Adhesion promoting compositions and method of improving fuel resistance of a coated article.
Inventor: SADVARY RICHARD J
IPC: C09D5/00
Filed: 2020-01-21
Abstract: The present invention is directed to film-forming compositions comprising: a) a non-chlorinated, linear polyolefin polymer comprising 0.5 to 10 percent by weight residues of an ethylenically unsaturated anhydride or acid; b) an aminoplast; and c) a component comprising: i) at least one non-chlorinated hydrocarbon having at least 18 carbon atoms and optionally aromatic groups and/or oxygen heteroatoms; and/or ii) an alkyd resin. The present invention is also drawn to methods of improving fuel resistance of a coated article, comprising: (1) applying the film-forming composition to a substrate to form a coated substrate; (2) optionally subjecting the coated substrate to a temperature for a time sufficient to cure the film-forming composition; (3) applying at least one curable film-forming composition to the coated substrate to form a multi-layer coated substrate; and (4) subjecting the multi-layer coated substrate to a temperature and for a time sufficient to cure all of the film-forming compositions.
Patent MX-2021010253-A (MX)
Title: Apparatus and method for measuring far-field luminous intensity and color characteristics of light sources.
IPC: G01M11/02
Filed: 2021-04-16
Abstract: An apparatus is provided for measuring far-field luminous intensity and color characteristics of a light source that includes a lamp test location for receiving a lamp for testing and a mirror positioned in a fixed light receiving position relative to the lamp test location and positioned in a fixed light transmitting position for reflecting a light beam from the lamp at a predetermined angle relative to the light receiving position. A measurement screen is positioned in a location relative to the mirror to receive the parabolically-condensed light image reflected from the mirror at the predetermined angle and a light detector is positioned to capture a light image reflected from the measurement screen. The light detector is configured to convert the reflected light image on the measurement screen to a digital signal and output the digital signal. A computer calibrated for measuring luminous intensity according to an algorithm processes the digital signal.
Patent MX-2021010598-A (MX)
Title: Pipe arrangement for transporting temperature control media.
Inventor: SCHAEFER THORSTEN
IPC: B29C49/00
Filed: 2021-09-02
Abstract: Pipe arrangement for transporting temperature control media, comprising a base body which is produced by means of blow molding and from which at least a first channel and a second channel are formed, wherein the first channel and the second channel have a first orientation towards one another in a first section and a second orientation towards one another in a second section, wherein the first orientation is different from the second orientation.
Patent MX-2021010804-A (MX)
Title: Staple height indicator for powered surgical stapler.
Inventor: WISE AUSTIN E
IPC: A61B17/115
Filed: 2020-02-26
Abstract: A surgical instrument includes a body assembly, a distally extending shaft assembly, and a distal stapling assembly configured to clamp, staple, and cut tissue. A first user feedback element is configured to visually inform a user of a first condition of the stapling assembly, and a second user feedback element is configured to visually inform the user of a second condition of the stapling assembly. A circuit board assembly includes a circuit board, a first light source configured to illuminate the first user feedback element, a second light source configured to illuminate the second user feedback element, and a light guide feature. The light guide feature is configured to direct light from the second light source toward the second user feedback element and simultaneously inhibit light emitted by the first light source from illuminating the second user feedback element.
Patent MX-2021011132-A (MX)
Title: Compounds and methods for reducing kcnt1 expression.
Inventor: FREIER SUSAN M
IPC: A61P25/08
Filed: 2020-03-13
Abstract: Provided are compounds, methods, and pharmaceutical compositions for reducing the amount or activity of KCNT1 RNA in a cell or subject, and in certain instances reducing the amount of KCNT1 protein in a cell or subject. These compounds, methods, and pharmaceutical compositions are useful to ameliorate at least one symptom or hallmark of a neurological condition. Such symptoms and hallmarks include seizures, encephalopathy, and behavioral abnormalities. Non-limiting examples of neurological conditions that benefit from these compounds, methods, and pharmaceutical compositions are epilepsy of infancy with migrating focal seizures (EIMFS), autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE), West syndrome, and Ohtahara syndrome.
Patent MX-2021012556-A (MX)
Title: System and method for extraction and cryopreservation of bone marrow.
Inventor: WOODS ERIK J
IPC: A01N1/02
Filed: 2020-03-30
Abstract: Methods are provided for extracting bone marrow cells from bone obtained from deceased donors, for preparing the bone marrow for cryopreservation and for obtaining desired cells from cryopreserved and fresh bone marrow.
Patent MX-2021013135-A (MX)
Title: 3-AMINO-4<i>H</i>-BENZO[<i>E</i>][1,2,4]THIADIAZINE 1,1-DIOXIDE DERIVATIVES AS INHIBITORS OF MRGX2.
Inventor: KONO MITSUNORI
IPC: C07D417/04
Filed: 2020-04-28
Abstract: Disclosed are compounds of Formula (1), tautomers thereof, and pharmaceutically acceptable salts of the compounds or tautomers, wherein L, R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup> and R<sup>5</sup> are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula (1), to pharmaceutical compositions which contain them, and to their use for treating diseases, disorders or conditions associated with MRGX2.
Patent MX-2021015076-A (MX)
Title: Adeno-associated virus compositions for arsa gene transfer and methods of use thereof.
Inventor: SEYMOUR ALBERT BARNES
IPC: C07K14/47
Filed: 2020-06-09
Abstract: Provided herein are adeno-associated virus (AAV) compositions that can express an arylsulfatase A (ARSA) polypeptide in a cell, thereby restoring the ARSA gene function. Also provided are methods of using the AAV compositions, and packaging systems for making the AAV compositions.
Patent MX-2021015749-A (MX)
Title: Controlling groups of electrical loads via multicast and/or unicast messages.
Inventor: BARD BENJAMIN F
IPC: H04L12/28
Filed: 2019-01-07
Abstract: A load control system (100) includes control devices for controlling electrical loads, such as a motorized window treatment (130) and lighting devices (112, 122). The control devices include load control devices, such as a lighting device (112, 122) for controlling an amount of power provided to a lighting load, and input devices, such as a remote control device (116) configured to transmit digital messages comprising lighting control instructions for controlling the lighting load via the lighting device. The remote control device (116) may communicate with the lighting device (112, 122) via an intermediary device, such as a hub device (180). The remote control device (116) detects a user interface event, such as a button press or a rotation of the remote control device. The remote control device (116) or the hub (180) device determines whether to transmit digital messages to as unicast messages or multicast messages based on the type of user interface event detected. The load control devices may also include a motorized window treatment (130). The input devices may also include a remote control device (150), an occupancy sensor (160), a daylight sensor (170), and a network device (190), such as a smart phone, which may include a visual display (192). The remote control device (116, 150) or the hub device (180) may transmit the digital message as a unicast message when the user interface event is determined to be an "on" event or an "off" event and the number of multicast messages transmitted within the predefined period of time is outside of a predefined threshold. The remote control device (116) may be a retrofit remote control device capable of covering a switch installed on the wall-mounted load control device (110). The remote control device (116, 150) or the hub device (180) may calculate a delay between the transmission of each unicast message. The delay may be injected between unicast messages to help ensure that the communication link is idle prior to the device sending the next unicast message.
Patent MX-2022004651-A (MX)
Title: Nicotinamide compound and herbicidal composition comprising compound.
Inventor: LEE ILL YOUNG
IPC: C07D401/12
Filed: 2020-10-21
Abstract: The present invention relates to a novel nicotinamide compound, a method for preparing same, and a herbicide including the compound. The compound of the present invention has high safety for wheat or corn and excellent herbicidal activity against flower-family weeds, sedge-family weeds, or broadleaf weeds, and thus is useful as a herbicide for post-emergence or pre-emergence treatment of weeds.
Patent MX-2022005360-A (MX)
Title: Ras inhibitors.
Inventor: AAY NAING
IPC: C07D513/22
Filed: 2020-11-04
Abstract: The disclosure features macrocyclic compounds, and pharmaceutical compositions and protein complexes thereof, capable of inhibiting Ras proteins, and their uses in the treatment of cancers.
Patent MX-2022006067-A (MX)
Title: Paper container.
Inventor: TANAKA ATSUSHI
IPC: B65D5/06
Filed: 2020-11-20
Abstract: In order to obtain a paper container which makes it easy to open the paper container and definitively indent the upper end section of a body-section panel thereof when opening the paper container while eliminating the risk of warping the shape thereof when forming the paper container, the present invention: establishes reference points 40 on the opening-side body-section panel 7, which is connected by a top-section horizontal folding line 25 to the opening-side gable-forming panel 23, in a manner such that said reference points 40 are separated by at least 3mm from the intersections 39 between the end sections of the top-section horizontal folding line 25 and the end sections of the body-section vertical folding lines 3, 4 on both sides of said body-section panel 7, and are located along said body-section vertical folding lines 3, 4; forms a downward-facing, curved first auxiliary folding line 43, the end sections 41, 42 of which are positioned so as to connect the reference points 40 or positions near said reference points 40 along the body-section vertical folding lines 3, 4 or separated from the body-section vertical folding lines 3, 4 and no higher than said reference points 40 in the height direction; and separates the end sections 41, 42 of the first auxiliary folding line 43, which connects positions near said reference points 40 along the body-section vertical folding lines 3, 4 or separated from the body-section vertical folding lines 3, 4 and no higher than said reference points 40 in the height direction, by at least 3mm from the intersections 39 and no more than 20% of the length of the top-section horizontal folding line 25.
Patent MX-2022006611-A (MX)
Title: Platform with variable forces for cultivation of wave energy.
Inventor: NEGRETE PÉREZ RODRIGO
IPC: F03B13/22
Filed: 2022-05-31
Abstract: The present invention relates to a variable force platform for wave energy cultivation based on a novel floating body design, which has top and side parts without a bottom piece for the air to remain inside the floating body, avoiding leaks because the surface stops it. Also, it has air inlets and outlets to control the air left therein, generating a buoyant and controllable force in the opposite direction since there is also a part of water inside the floating body that weighs. Additionally, it consists of a flotation system designed with shock absorbers that raise and lower the platform for transportation or to improve energy harvesting, anchorage, and submersion system for harvesting energy above and underwater, and a direct storage system and controlled conversion for wave energy, applying different forces to different waves and directly storing the power of water pressure within an independent network.
Patent MX-2022006676-A (MX)
Title: Novel molecules for therapy and diagnosis.
Inventor: KOSCO-VILBOIS MARIE
IPC: C07K16/18
Filed: 2020-12-04
Abstract: The present invention relates to biparatopic antigen-binding molecules, such as biparatopic antibodies or functional fragments thereof, and mixtures comprising at least two monospecific antibodies or functional fragments thereof, that can be employed for the prevention, alleviation, treatment and/or diagnosis of diseases, disorders and abnormalities associated with CNS proteins such as alpha-synuclein (Î±-synuclein, A-synuclein, aSynuclein, A-syn, Î±-syn, aSyn, a- syn), Tau, TDP-43, ASC, NLRP3, C5a, C1q, C3, huntingtin or prion protein. The present invention further relates to the use of the molecules of the invention for determining a predisposition to a disorder, disease or abnormality, monitoring residual disorder, disease or abnormality associated with CNS proteins such as alpha-synuclein (Î±-synuclein, A-synuclein, aSynuclein, A-syn, Î±-syn, aSyn, a-syn), Tau, TDP-43, ASC, NLRP3, C5a, C1q, C3, huntingtin or prion protein, or predicting the responsiveness of a patient who is suffering from such a disorder, disease or abnormality to the treatment with a certain medicament.
Patent MX-2022007025-A (MX)
Title: Method for moving a vehicle to a component of an object at a distance therefrom (coordinate transformation).
Inventor: MÜLLER MARK
IPC: B60W30/06
Filed: 2022-06-08
Abstract: A method for moving a vehicle to a component of an object at a distance therefrom, the vehicle having a navigation module which has a camera and an evaluation electronics, and an identification element is attached to the object in a predetermined position in such a way that it is recognized by the camera in a far range (Dmax) of the vehicle from the object, and a reverse driving line of the vehicle is calculated by the evaluation electronics from the perspective position of the camera in relation to the identification element. The method improves the approach of a vehicle to a stationary object. In a start position (S) of the vehicle, the navigation module generates a static object coordinate system (KO) and a reverse driving line is calculated from the start position (S) to a pre-positioning point (SVi, SVii, SViii).
Patent MX-2022007176-A (MX)
Title: 4-((2-oxopyri din-1 (2h)-yl)methyl)benzamides for treating alpha1 -antitrypsin deficiency.
Inventor: HUNTINGTON JAMES ANDREW
IPC: A61P11/00
Filed: 2020-12-11
Abstract: The invention relates to five benzamide compounds of formula (1) and pharmaceutical compositions containing the compounds. The compounds may be inducers of alpha1-antitrypsin (A1AT), and may be used in the treatment of a disease or disorder such as alpha1-antitrypsin deficiency (A1AD or AATD).
Patent MX-2022012967-A (MX)
Title: Treatment of hidradenitis suppurativa.
Inventor: SIMARD JOHN
IPC: A61K39/00
Filed: 2021-04-16
Abstract: Hidradenitis suppurativa can be treated by administering a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a therapeutically effective amount of an agent that selectively binds IL-1Î±.